2011年2月11日起,尼美舒利致儿童肝功能受损的报道不断爆出,各大媒体高度关注,同时,国家对药品不良反应的监测与上报制度再次成为舆论关注焦点。不少人质疑我国的药物不良反应监督制度,要求相关部门加大监管力度,向国外看齐。 Since February 11, 2011, the reports that nimesulide has impaired liver function in children have been constantly reported and the major media are paying close attention to it. At the same time, the national monitoring and reporting system for adverse drug reactions has once again become the focus of public opinion. Many people have questioned the system of supervision over the adverse drug reactions in our country, requiring relevant departments to step up their supervision and control and align themselves with foreign countries.